1. Market Research
25 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)

  • $ 850
  • June 2020
  • 85 pages

Aspirin Cardio, Adempas Oncology Liver cancer, renal cell carcinoma, prostate cancer, and colorectal cancer etc.

  • Anticoagulant
  • Pathology
  • Salicylic Acid
  • World
  • Daiichi Sankyo Company

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • August 2016
  • 411 pages

BOTH GUIDELINES DO NOT RECOMMEND OFFERING ASPIRIN MONOTHERAPY TO AF PATIENTS SOLELY FOR STROKE PREVENTION.

  • Cardiovascular Drug
  • Hospital
  • Salicylic Acid
  • Therapy
  • Daiichi Sankyo Company

Consumer Health in Japan

  • $ 2650
  • October 2019
  • 10 pages

The plight of aspirin was underlined when Bayer Yakuhin announced the discontinuation of Bayer Aspirin from January 2019.

  • Ophthalmic Solution
  • Salicylic Acid
  • Japan
  • Daiichi Sankyo Company
  • Taisho Pharmaceutical Co., Ltd.

Pharmaceuticals Global Industry Almanac 2014-2023

  • $ 2995
  • April 2019
  • 538 pages

These products are offered under known brands such as Claritin, Aspirin, Aleve, Bepanthen/ Bepanthol, Canesten, Dr.

  • Pharmaceutical
  • Salicylic Acid
  • East Asia
  • Market Size
  • Daiichi Sankyo Company

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

  • $ 4995
  • December 2017
  • 228 pages

Bayer has several products indicated within CVD, including Aspirin Cardio (aspirin).

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • Salicylic Acid
  • Daiichi Sankyo Company

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • June 2017
  • 203 pages

IN THE US, ORTHOPEDIC SURGEONS PREFER ASPIRIN DUE TO ITS LOWER BLEEDING EFFECTS.

  • Hospital
  • Salicylic Acid
  • Therapy
  • Daiichi Sankyo Company
  • Portola Pharmaceuticals, Inc.

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

  • $ 4995
  • June 2017
  • 1 pages

Other NSAIDs - such as ibuprofen and aspirin - non-selectively inhibit COX enzymes, inhibiting the role of COX-## in the protection of GI mucosa and kidney hemodynamics, and in thrombosis formation.

  • Pain Relief
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Daiichi Sankyo Company

Global Venous Thromboembolism Therapeutics Market 2017-2021

  • $ 2500
  • February 2017
  • 82 pages

Eliquis and Xarelto are recommended as efficacious alternatives of warfarin or aspirin for anticoagulation and stroke prevention by the American Heart Association and the American Stroke Association.

  • Salicylic Acid
  • Therapy
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company
  • Johnson & Johnson

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • $ 4995
  • March 2017
  • 1 pages

Mild pain is treated with non-opioid analgesics such as acetaminophen and paracetamol, or nonsteroidal anti-inflammatory drugs (NSAID).

  • Blood Disease
  • Cancer
  • Salicylic Acid
  • Therapy
  • Daiichi Sankyo Company

US Anticoagulation Therapy Market by Product, PT/INR Devices, Service Type, Type of Clinic - Forecast to 2022

  • $ 4950
  • November 2017
  • 88 pages

Patients suffering from mechanical prosthetic health valves usually require lifelong anticoagulation therapy or continued at least until the risk of hemorrhage becomes unacceptably high, and aspirin becomes the alternative treatment.

  • Clinic
  • Salicylic Acid
  • United States
  • Daiichi Sankyo Company
  • Portola Pharmaceuticals, Inc.

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • August 2016
  • 416 pages

ALL PATIENTS RECEIVED STANDARD ASPIRIN THERAPY.

  • Epidemiology
  • Hospital
  • Salicylic Acid
  • Therapy
  • Daiichi Sankyo Company

OTC Pharmaceuticals Global Industry Guide_2016

  • $ 1495
  • October 2016
  • 271 pages

Sales growth has been sustained by innovation and extensions to the product, such as the production of Aspirin Cardio and Aspirin Plus C.

  • OTC
  • Pharmaceutical
  • Salicylic Acid
  • Market Size
  • Daiichi Sankyo Company

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • November 2016
  • 419 pages

THE VACCINE IS CONTRAINDICATED FOR INDIVIDUALS WITH SEVERE ALLERGIC REACTIONS TO EGG, GENTAMICIN, GELATIN, AND ARGININE, AS WELL AS CHILDREN AND ADOLESCENTS ON ASPIRIN THERAPY.

  • Epidemiology
  • Influenza
  • Salicylic Acid
  • Vaccine
  • Daiichi Sankyo Company

OTC Pharmaceuticals Global Industry Almanac_2016

  • $ 2995
  • October 2016
  • 491 pages

Sales growth has been sustained by innovation and extensions to the product, such as the production of Aspirin Cardio and Aspirin Plus C.

  • OTC
  • Pharmaceutical
  • Salicylic Acid
  • Market Size
  • Daiichi Sankyo Company

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

  • $ 4995
  • December 2016
  • 110 pages

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline Summary Hypertension is a serious and common medical condition ...

  • Antihypertensive
  • Cardiovascular Drug
  • Hypertension
  • Therapy
  • Daiichi Sankyo Company

OTC Pharmaceuticals Global Group of Eight (G8) Industry Guide_2016

  • $ 1495
  • October 2016
  • 185 pages

Sales growth has been sustained by innovation and extensions to the product, such as the production of Aspirin Cardio and Aspirin Plus C.

  • OTC
  • Pharmaceutical
  • Salicylic Acid
  • Market Size
  • Daiichi Sankyo Company

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

  • $ 4995
  • January 2017
  • 1 pages

The vaccine is contraindicated for people with severe allergic reactions to egg, gentamicin, gelatin, and arginine, as well as children and adolescents on aspirin therapy.

  • Influenza
  • Salicylic Acid
  • Therapy
  • Vaccine
  • Daiichi Sankyo Company

Analyzing Generics Market in Japan 2017

  • $ 850
  • March 2017
  • 85 pages

In 2015, it also launched generic versions of Axert (almotriptan malate) tablets, ##. ## mg and ##. ## mg; Aggrenox (aspirin/ extended-release dipyridamole) capsules to lower the risk of stroke in people who have had a mini-stroke or stroke due to a blood clot; Actonel (risedronate sodium)

  • Pharmaceutical
  • Salicylic Acid
  • Allergan plc
  • Daiichi Sankyo Company
  • Sanofi S.A.

OTC Pharmaceuticals in Japan

  • $ 350
  • September 2016
  • 35 pages

Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/ gels), plasters & bandages (adhesive bandages/ plasters, first aid

  • Pharmaceutical
  • Salicylic Acid
  • Japan
  • Daiichi Sankyo Company
  • Johnson & Johnson

IMS Country Review 2017: Japan

  • $ 3820
  • July 2017
  • 1 pages

INHIBITORS Leading Corporations 2016 Rank Nationality 2016 $ (' ##) 2016 Mkt Share $ (%) 2012 AV EI ($) AV Growth $ (%) 2016 Growth $ (%) LEADING ## CORPORATIONS ASPIRIN BAYER LIMAPROST ALFA.

  • Pharmaceutical
  • Salicylic Acid
  • Japan
  • United States
  • Daiichi Sankyo Company
View report >

Therapy Market

  • January 2017
  • 159 pages
  • Pharmaceutical
  • Therapy
  • Daiichi Sankyo Company
  • Genentech, Inc.
  • Mitsubishi Corporation

Therapy Market January 2014

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on